Sumitomo Chemical Co Ltd (SOMMF) reports significant improvements in core operating income and free cash flow, while addressing challenges in specific segments.

Sumitomo Chemical Company, Limited ( OTCPK:SOMMY) Q3 2025 Results Conference Call February 3, 2025 3:00 AM ET Takato Watabe - Morgan Stanley MUFG Securities Makio Yamada - Mizuho Securities Go ...

Sumitomo Pharma recorded core operating income of JPY19.9 billion, a significant year-over-year improvement of JPY116.2 billion. This was attributed to streamlined operations in North America, reduced ...